AQR Capital Management
CERE

AQR Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

AQR Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
2024
Q2 		$810K Buy
2024
Q1 		$835K Buy
2023
Q4 		$830K Buy
2023
Q3 		– Sell
2023
Q2 		$223K Sell
2023
Q1 		$333K Sell
2022
Q4 		$517K Sell
2022
Q3 		$675K Buy
2022
Q2 		$599K Buy
2022
Q1 		$325K Buy